Athersys dealt financial blow with loss of $100M stock purchase agreement


The biotechnology investment fund had the right to terminate the purchase agreement after Athersys laid off three top executives during a restructuring last month.

Previous Three questions with the American Cancer Society of Hawaii
Next New power buyer allows people to compete against companies offering cash in Denver’s housing market